CHO-CLD Service from Gene Synthesis to GMP‑Ready Cell Banks

On-Demand Webinar | CHO-CLD Service from Gene Synthesis to GMP-Ready Cell Banks

CHO Cell line development (CLD) is a critical step in biopharmaceutical manufacturing, directly impacting speed-to-clinic, quality, and cost per dose. In this webinar, experts from Sartorius will share insights from our Cell Line Development Centre of Excellence on how to overcome key challenges such as achieving high productivity, ensuring consistent product quality, and securing genetic stability. Learn how AI/ML-driven clone selection, smart media strategies, and automated workflows accelerate timelines and de-risk your CHO CLD projects. We will also highlight approaches for biosimilars, novel molecules, and difficult-to-express proteins, as well as innovations in process intensification and perfusion. Discover how our integrated platform and expertise enable reliable, scalable, and flexible solutions tailored to your needs—supporting a faster, more cost-effective path from DNA to clinic

What You Will Learn:

Learn strategies to boost productivity and product quality in CLD.
Discover tools to accelerate speed-to-clinic and reduce risk.
Explore solutions for biosimilars and complex molecules.

Clear form data

Please Complete the Form

First Name *

Last Name *

Email *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form to Watch

Kristin Thiele

Manager of Molecular Science and Cell Line Technology

Kristin Thiele is a Product Development Manager specializing in Molecular Science and Cell Line Technologies at Sartorius. She leads a team focused on advancing CHO DG44 cell line development platforms, and drives innovation to meet the evolving needs of the biopharmaceutical industry.

Melanie Mann

Manager of CLD Operations

Melanie Mann is the Manager of Cell Line Development Operations at Sartorius, where she leads cross-functional teams to drive projects from vector design to research cell bank delivery. Melanie ensures excellence at every stage, delivering fully characterized, scalable cell lines ready for clinical manufacturing.

Yash Patel, Ph.D.

Product Manager

Dr. Yash D. Patel is a Product Manager for Cell Line Development at Sartorius and has been with the company since August 2021. He has a PhD in chemical and biological engineering from the University of Sheffield and 15 years of experience in CHO cell line development and engineering. He has worked with CDMOs such as Lonza and collaborated with AstraZeneca to patent novel CLD technology and author numerous publications within the field.

Christoph Zehe, Ph.D.

Research Fellow

Christoph Zehe holds a Ph.D. in molecular and cell biology from the University of Heidelberg. He joined Cellca GmbH in 2007 (acquired by Sartorius in 2015), where he helped establish a leading platform technology for generating high-expressing cell lines. From 2011 to 2018, he held various R&D roles and currently serves as a Sartorius Research Fellow, focusing on technology development in synthetic biology, molecular biology, and cell biology.